Blinatumomab, CAS [[853426-35-4]]

Produktübersicht

• Artikelname: Blinatumomab, CAS [[853426-35-4]]
• Artikelnummer: TGM-T78317
• Hersteller Artikelnummer: T78317
• Alternativnummer: TGM-T78317-1MG,TGM-T78317-5MG,TGM-T78317-10MG,TGM-T78317-100UG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: bscCD19xCD3 , MT-103 , AMG10 , AMG-10 , MT103

Produktbeschreibung

Blinatumomab (AMG-10,MT-103) is a CD19/CD3 bispecific B-cell and T-cell binding antibody that directs T-cells to attack cancer cells by binding to both CD3 on T-cells and CD19 on cancer cells, and is used in acute lymphoblastic leukemia and non-Hodgkins lymphoma.

Produkteigenschaften

• Reinheit: >90%
• CAS Nummer: [853426-35-4]
• Target-Kategorie: Immunology/Inflammation related|||Integrin